SFF
Recent years have seen a proliferation of alternative container formats for injectable products in addition to the standard vial. All of these containers have features and benefits that may make them more suitable than others when patient centricity is a target. Early consideration of the unique needs of the biologic formulation and careful planning of the final manufacturing process is vital to ensure the right container is chosen.
The support of an expert contract development and manufacturing organisation (CDMO) can help ensure the final container and manufacturing method are suitable for the formulation.
In this eBook, we will explore the steps developers and manufacturers can take and the decisions to make to ensure the final container and sterile fill and finish process is fit for purpose.
Download the full eBook below by filling out your details.